Topic: regenerative medicine
Recent biotech discoveries include a compound that interrupts neuropathic pain and a strategy for preventing drug- or noise-induced hearing loss.
A Harvard-led research team has identified a brain protein that exacerbates memory loss with age or PTSD.
The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.
Researchers confirmed that the pancreas contains stem cells that can become insulin-producing cells.
Scientists at the University of Cambridge have shown in animal models that reprogramming patients’ own skin cells may be an effective way to treat MS.
Scientists at Stanford University believe stem cells can teach the immune system to recognize and attack cancer.
Celltex Therapeutics and Texas A&M Institute for Regenerative Medicine hope to have a stem cell-derived therapy for Alzheimer’s within three years.
The agreements stand to create investment vehicles with more than $1 billion under management and an interest in bringing British innovation to China.
Boehringer Ingelheim is deepening its venture fund pockets from €100 million to €250 million as it looks to change up its investment strategy.
Scientists at the University of California, San Francisco are recreating early development, then leaving it up to cells to fold themselves into complex human tissues.